Previous 10 | Next 10 |
Gainers: BNED +7.6% . DPW +5.0% . RMNI +3.9% . OTCQB:KSHB +3.6%. BCOV +3.4% . More news on: Barnes & Noble Education, Inc., DPW Holdings, Inc., Rimini Street, Inc., Stocks on the move, Read more ...
It was another rocky week for the NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ), which opened at 3,243.06 points on Monday (August 26) and reached a high of 3,269.62 points on Tuesday (August 27). By Friday (August 30), the index had settled at 3,230.77 points as of 12:52 p.m. ED...
Shares of Ireland-based Prothena Corporation ( PRTA ) have fallen by 38% over the past year and by over 60% over the past five years. Recently, the stock price jumped 26% on news that well-known healthcare institutional investor EcoR1 Capital disclosed a 23.6% stake . A quick glance at the ...
Gainers : Ossen Innovation (NASDAQ: OSN ) +41% . Sears Hometown and Outlet Stores (NASDAQ: SHOS ) +27% . Koss (NASDAQ: KOSS ) +25% . Standex International (NYSE: SXI ) +24% . Caleres (NYSE: CAL ) +23% . Prothena Corporation (NASDAQ: PRTA ) +23% . Town Sports International Holdin...
Prothena (NASDAQ: PRTA ): Q2 GAAP EPS of -$0.40 beats by $0.18 . More news on: Prothena Corporation plc, Earnings news and commentary, Healthcare stocks news, Read more ...
Net cash used in operating and investing activities was $12.2 million in the second quarter and $29.7 million for the first six months of 2019; quarter-end cash and restricted cash position of $402.2 million provides funding to advance neuroscience pipeline Appointed Paula K. Cobb to Pr...
DUBLIN, Ireland, July 30, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the second quarter and first six months of 2019 on August 6, 2019 after the close of the U.S. financial markets. Consistent w...
DUBLIN, Ireland, July 01, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, announced today the appointment of Paula Cobb to its Board of Directors. “As a biotechnology executive with wide-ranging global development, business s...
DUBLIN, Ireland, July 01, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company, announced today the appointment of Paula Cobb to its Board of Directors. “As a biotechnology executive with wide-ranging global development, business s...
Quick Take Prevail Therapeutics ( PRVL ) has filed to raise gross proceeds of $125 million from a U.S. IPO, according to an S-1/A registration statement . The firm is developing Adeno-Associated Virus-based [AAV-based] gene therapies for the treatment of serious neurodegenerative diseases...
News, Short Squeeze, Breakout and More Instantly...
Prothena Corporation plc Company Name:
PRTA Stock Symbol:
NASDAQ Market:
Prothena Corporation plc Website:
2024-07-03 23:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-02 10:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Prothena to receive $80 million from Bristol Myers Squibb for exclusive global license to PRX019, a potential treatment of neurodegenerative diseases with an undisclosed target Prothena will initiate a Phase 1 clinical trial for PRX019 in 2024 Prothena Corporation plc (NASDAQ:PRTA),...